Caltrans bike funds
Caltrans has awarded community-based transportation planning grants to Buellton and Grover Beach to create master plans for bikeways and trails. Buellton received $100,000. Its plan will include a series of interactive public meetings and workshops to integrate the community’s priorities. Grover Beach received $11,520 to collect community input and create a bicycle master plan. Read More →
Airport terminal groundbreaking
A groundbreaking ceremony to mark the beginning of construction for the $32 million terminal project at the Santa Barbara Municipal Airport was held on Oct. 22. The project includes construction of a new two-story 67,000-square-foot terminal built in Spanish Colonial Revival architecture, reconfiguration and landscaping of a new short-term parking lot, construction of a Read More →
Dole shares fall after IPO
Produce giant Dole Food Co.’s initial public offering has borne less fruit than the company hoped. The Westlake Village firm’s shares fell Oct. 23 after hitting the market at a lower-than-expected price, a possible sign that investors feel billionaire majority owner David Murdock overreached in tapping the public markets to pay off some of his Read More →
Navy Secretary unveils plans for Green Fleet
[Editor’s note: Correction appended below.] Calling for a “Green Fleet,” U.S. Secretary of the Navy Ray Mabus outlined an ambitious goal to use non-fossil fuels to produce half of the energy for the U.S. Navy’s sea and shore vehicles at an Oct. 22 event in Santa Barbara. In a speech hosted by the Santa Barbara Read More →
UCSB skilled trade union agrees to furlough days
A union representing skilled-trade workers at the University of California, Santa Barbara, has agreed to share the pain of state budget cuts at the school. Over the next year, about 85 electricians, mechanics, plumbers, locksmiths and other trade workers at UCSB will take the same furlough days as non-union university employees, the school said in Read More →
Breaking news: Amgen drug approval withheld
Amgen suffered a setback Oct. 19 as federal regulators withheld approval of a new drug that investors hope will be the Thousand Oaks company’s next blockbuster. The Food and Drug Administration held up approval for denosumab, a treatment for bone loss in older women. Federal regulators want more information on how Amgen will monitor the Read More →
